Medical Capital executive gets 10-year sentence for private placement fraud

Joseph J. Lampariello also ordered to pay nearly $40 million in restitution.
AUG 25, 2016
A former top executive of Medical Capital Holdings Inc., a private placement-turned-Ponzi scheme that destroyed dozens of broker-dealers, is heading to prison. Joseph J. Lampariello, 62, the one-time president and chief operating officer of Medical Capital Holdings, was sentenced on Monday to 10 years and one month in federal prison by U.S. district judge David O. Carter. In addition to the prison term, Mr. Lampariello was ordered to pay close to $40 million in restitution to investors who had lost millions of dollars. Medical Capital Holdings was a medical receivables financing company that operated in southern California. Raising money through a network of independent broker-dealers, the company oversaw funds that were intended to purchase account receivables from accredited medical providers, make secured loans and provide money for general operating expenses. Over 11 months in 2008 and 2009, Mr. Lampariello misappropriated funds invested with one of the MedCap series of deals and used the money to make payments to prior investors and to pay himself administrative fees, according to a statement from the U.S. Attorney's office for the central district of California. Through Medical Capital, Mr. Lampariello defrauded more than 700 investors of nearly $49 million, according to the U.S Attorney's statement. From 2003 to 2009, Medical Capital raised almost $2 billion, purportedly to buy discounted medical receivables such as unpaid doctor or hospital bills that Medical Capital would then collect at full price. “Mr. Lampariello's sentence properly reflects the significant harm he caused to hundreds of victims,” said U.S. attorney Eileen M. Decker, in the statement. “This defendant's false promises were designed only to provide wealth for himself, and he must now pay for that greed.” Dozens of independent broker-dealers sold MedCap notes and wiped out millions of dollars in investor cash. Brokers who sold them earned commissions of 7%. Like other private placement sponsors, Medical Capital paid broker-dealers a so-called “due diligence” fee of 1%. Securities regulators later found many of the broker-dealers that sold Medical Capital and other fraudulent private placements before the credit crisis failed to perform adequate due diligence on the high-risk deals. Many of the B-Ds went out of business due to massive costs from lawsuits brought by investors looking to regain money lost in the fraud. After the SEC charged Medical Capital with fraud in 2009, it took the company over. At the time, the company owned a medical nuclear reactor, as well as two closed hospitals that had lost their operating licenses. It was also producing a movie about a Mexican Little League team. The company also owned a 115-foot yacht, the Homestretch.

Latest News

Carnegie Investment Counsel sued over valuation suppression
Carnegie Investment Counsel sued over valuation suppression

Retiring RIA seller David Laidlaw alleges the Carnegie valued his stake on $11.7 million EBITA while pitching potential buyers on $21.3 million.

Arch pushes AI portfolio monitoring into pre-investment due diligence
Arch pushes AI portfolio monitoring into pre-investment due diligence

New tool gives RIAs and family offices AI help vetting private market deals, with some users reportedly halving review time.

$4.5M raised on trust alone: SEC alleges affinity fraud in merchant lending
$4.5M raised on trust alone: SEC alleges affinity fraud in merchant lending

Investors got projected returns dressed up as real ones, SEC says

Treasury sets auto-enrollment rules for Trump Accounts, potentially adding 60 million more children
Treasury sets auto-enrollment rules for Trump Accounts, potentially adding 60 million more children

Parents must still act to get the $1,000 federal seed and employer contributions, giving financial advisors a role in the rollout.

FINRA bars former LPL broker for stealing $1.7 million from customers
FINRA bars former LPL broker for stealing $1.7 million from customers

FINRA booted Rudy Anguiano from the industry for “conversion - the intentional and unauthorized taking of another person’s property.”

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor

SPONSORED Direct indexing webinar targets tax-loss harvesting amid market swings

Northern Trust’s Ken Lassner shows advisors how to convert volatility into after-tax portfolio gains